. 2011 Aug 7;31(5):739–745. doi: 10.1007/s10096-011-1367-y

Table 2.

Distribution of minimum inhibitory concentrations (MICs) among the diverse groups and correlation with their genotypes

S.aureus, N,=128 IE/BSI	Range/MIC₉₀ DAP (mg/l)	Range/MIC₉₀ LNZ (mg/l)	Range/MIC₉₀ SYN (mg/l)	Range/MIC₉₀ TGC (mg/l)	Range/MIC₉₀ VAN (mg/l)	Range/MIC₉₀ TEC (mg/l)	hVISA n/total (%)	VAN, range of MICs in which hVISA were found (mg/l)	TEC, range of MICs in which hVISA were found (mg/l)	hVISA STs	hVISA-MRSA Clone (ST-SCCmec)
IE-MSSA	0.12–1/ 0.5	0.5–4/ 2	0.12–2/ 1	0.12–0.5/ 0.25	0.5–2/ 2	0.25–2/ 1	10/76 (13.1%)	0.5–1	0.25–1	8, 30, 45, 121, 7, 12
IE-MRSA	0.06–1/ 1	0.75–2/ 2	0.25–2/ 1	0.12–0.5/ 0.5	0.5–2/ 2	0.5–2/ 2	7/76 (9.2%)	1–2	1–2	8, 228, 247	8-IA/IVc (n=2), 228-I (n=3), 247-IA (n=2)
BSI-MSSA	0.06–2/ 1	0.5–4/ 4	0.25–1/ 0.5	<0.06–1/ 0.25	0.5–2/ 2	0.25–2/ 2	6/52 (11.5%)	1	0.5–1	5, 8, 30, 15
BSI-MRSA	0.06–1/ 1	1–4/ 4	0.25–1/ 0.5	<0.06–0.25/ 0.25	1–2/ 2	0.5–2/ 2	2/52 (3.8%)	2	1–2	228	228-I (n=2)

DAP, daptomycin; LNZ, linezolid; TGC, tigecycline; SYN, synercid (quinupristin/dalfoprisitin); VAN, vancomycin; TEC, teicoplanin